Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers

NCT01363063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Ketorolac tromethamine
DRUG: Ketorolac tromethamine

Sponsor

Egalet Ltd